STOCK TITAN

[144] Arcellx, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

ACLX: A Form 144 notice indicates a planned sale of up to 5,946 shares of common stock with an aggregate market value of $488,999.04. The shares are listed on NASDAQ and the sale is approximately dated October 3, 2025, with Morgan Stanley Smith Barney LLC named as broker.

The securities were acquired as Restricted Stock Units on January 3, 2025. The filing lists 55,458,912 shares outstanding as context.

ACLX: un avviso di Form 144 indica una vendita prevista di fino a 5.946 azioni ordinarie con un valore di mercato complessivo di $488.999,04. Le azioni sono quotate su NASDAQ e la vendita è approssimativamente prevista per 3 ottobre 2025, con Morgan Stanley Smith Barney LLC indicato come broker.

Le azioni sono state acquisite come Unità di azioni vincolate (RSU) il 3 gennaio 2025. La presentazione elenca 55.458.912 azioni in circolazione come contesto.

ACLX: un aviso de Form 144 indica una venta prevista de hasta 5.946 acciones ordinarias con un valor de mercado agregado de $488.999,04. Las acciones cotizan en NASDAQ y la venta está fechada aproximadamente para el 3 de octubre de 2025, con Morgan Stanley Smith Barney LLC designado como corredor.

Los valores se adquirieron como Restricted Stock Units el 3 de enero de 2025. La presentación lista 55.458.912 acciones en circulación como contexto.

ACLX: Form 144 공지에 따르면 최대 5,946주의 일반 주식 매매 예정이 있으며 총 시가가 $488,999.04이다. 주식은 NASDAQ에 상장되어 있으며 매매 예정일은 대략 2025년 10월 3일로 보이고 중개인은 Morgan Stanley Smith Barney LLC로 명시되어 있다.

증권은 제한 주식 단위2025년 1월 3일에 취득되었다. 공시에는 맥락상 55,458,912주가 유통 중으로 기재되어 있다.

ACLX : un avis Form 144 indique une vente prévue jusqu'à 5 946 actions ordinaires avec une valeur de marché agrégée de 488 999,04 $. Les actions sont cotées sur NASDAQ et la vente est estimée autour de la date 3 octobre 2025, Morgan Stanley Smith Barney LLC étant nommé courtier.

Les valeurs mobilières ont été acquises sous forme de Restricted Stock Units le 3 janvier 2025. Le dépôt indique 55 458 912 actions en circulation comme contexte.

ACLX: Eine Form 144-Mitteilung weist auf einen geplanten Verkauf von bis zu 5.946 Aktien Stammaktien mit einem gesamten Marktwert von 488.999,04 $ hin. Die Aktien sind an der NASDAQ notiert und der Verkauf ist voraussichtlich auf den 3. Oktober 2025 datiert, wobei Morgan Stanley Smith Barney LLC als Broker benannt ist.

Die Wertpapiere wurden am 3. Januar 2025 als Restricted Stock Units erworben. Die Einreichung führt 55.458.912 ausstehende Aktien als Kontext auf.

ACLX: إشعار Form 144 يشير إلى بيع مخطط له حتى 5,946 سهماً من الأسهم العادية بقيمة سوقية إجمالية قدرها $488,999.04. الأسهم مدرجة في NASDAQ ويتم تاريخ البيع تقريبيًا في 3 أكتوبر 2025، مع ذكر Morgan Stanley Smith Barney LLC كوسيط.

تم اقتناء الأوراق المالية كـ وحدات الأسهم المقيدة في 3 يناير 2025. تقرر التأكيد بأن 55,458,912 سهماً قائمًا كخلفية.

ACLX: Form 144 通知表示计划出售最多 5,946 股普通股,综合市场价值为 $488,999.04。这些股票在 NASDAQ 上上市,预计出售日期大致为 2025年10月3日,Morgan Stanley Smith Barney LLC 被列为经纪商。

证券是在 2025年1月3日限制性股票单位(Restricted Stock Units)形式取得。备案列出 55,458,912 股在外流通 作为背景信息。

Positive
  • None.
Negative
  • None.

ACLX: un avviso di Form 144 indica una vendita prevista di fino a 5.946 azioni ordinarie con un valore di mercato complessivo di $488.999,04. Le azioni sono quotate su NASDAQ e la vendita è approssimativamente prevista per 3 ottobre 2025, con Morgan Stanley Smith Barney LLC indicato come broker.

Le azioni sono state acquisite come Unità di azioni vincolate (RSU) il 3 gennaio 2025. La presentazione elenca 55.458.912 azioni in circolazione come contesto.

ACLX: un aviso de Form 144 indica una venta prevista de hasta 5.946 acciones ordinarias con un valor de mercado agregado de $488.999,04. Las acciones cotizan en NASDAQ y la venta está fechada aproximadamente para el 3 de octubre de 2025, con Morgan Stanley Smith Barney LLC designado como corredor.

Los valores se adquirieron como Restricted Stock Units el 3 de enero de 2025. La presentación lista 55.458.912 acciones en circulación como contexto.

ACLX: Form 144 공지에 따르면 최대 5,946주의 일반 주식 매매 예정이 있으며 총 시가가 $488,999.04이다. 주식은 NASDAQ에 상장되어 있으며 매매 예정일은 대략 2025년 10월 3일로 보이고 중개인은 Morgan Stanley Smith Barney LLC로 명시되어 있다.

증권은 제한 주식 단위2025년 1월 3일에 취득되었다. 공시에는 맥락상 55,458,912주가 유통 중으로 기재되어 있다.

ACLX : un avis Form 144 indique une vente prévue jusqu'à 5 946 actions ordinaires avec une valeur de marché agrégée de 488 999,04 $. Les actions sont cotées sur NASDAQ et la vente est estimée autour de la date 3 octobre 2025, Morgan Stanley Smith Barney LLC étant nommé courtier.

Les valeurs mobilières ont été acquises sous forme de Restricted Stock Units le 3 janvier 2025. Le dépôt indique 55 458 912 actions en circulation comme contexte.

ACLX: Eine Form 144-Mitteilung weist auf einen geplanten Verkauf von bis zu 5.946 Aktien Stammaktien mit einem gesamten Marktwert von 488.999,04 $ hin. Die Aktien sind an der NASDAQ notiert und der Verkauf ist voraussichtlich auf den 3. Oktober 2025 datiert, wobei Morgan Stanley Smith Barney LLC als Broker benannt ist.

Die Wertpapiere wurden am 3. Januar 2025 als Restricted Stock Units erworben. Die Einreichung führt 55.458.912 ausstehende Aktien als Kontext auf.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ACLX Form 144 filing disclose?

A planned sale of up to 5,946 common shares with an aggregate market value of $488,999.04.

When is the approximate sale date noted in the ACLX Form 144?

The filing lists an approximate sale date of October 3, 2025.

How and when were the ACLX shares acquired?

They were acquired as Restricted Stock Units on January 3, 2025.

Which broker is named for the ACLX Form 144 sale?

The broker is Morgan Stanley Smith Barney LLC (Executive Financial Services).

On which exchange are the ACLX shares listed?

The shares are listed on NASDAQ.

How many ACLX shares are outstanding according to the notice?

The filing lists 55,458,912 shares outstanding.

What class of ACLX securities is included in the planned sale?

The filing covers common stock.
ARCELLX INC

NASDAQ:ACLX

ACLX Rankings

ACLX Latest News

ACLX Latest SEC Filings

ACLX Stock Data

4.93B
45.57M
13.45%
106.11%
12.65%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
REDWOOD CITY